Physician profile
John A Banzer
NPI 1912933375
$10,331.55
in general payments reported to CMS, 2019-2025
47 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,106 · 2020: $1,077 · 2021: $1,104 · 2022: $1,899 · 2023: $1,749 · 2024: $2,031 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,126 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,126.13 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,513.65 | 2019-2025 | Jardiance, Glyxambi, Tradjenta |
| Amgen INC. | $1,275.87 | 2019-2025 | Repatha, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $874.22 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $829.61 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Novo Nordisk INC | $800.64 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $771.79 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $742.39 | 2021-2025 | |
| Pfizer INC. | $597.76 | 2019-2025 | |
| Boston Scientific Corporation | $312.58 | 2019-2024 | Bodyguardian, Watchman Access System |
| Amarin Pharma, INC. | $248.67 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $241.42 | 2023-2025 | Amvuttra, Onpattro |
| Janssen Pharmaceuticals, INC | $238.50 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $237.98 | 2023-2024 | Verquvo |
| Xeris Pharmaceuticals, INC. | $167.85 | 2021-2023 | Gvoke Hypopen |
| Kiniksa Pharmaceuticals International, Plc | $141.84 | 2024 | Arcalyst |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Banzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.